Brief: Vallon Pharmaceuticals Reports Fiscal Year 2021 Financial Results And Provides Business Update

GRI Bio

14/02/2022 21:23

Feb 14 (Reuters) - Vallon Pharmaceuticals Inc  VLON.O :
    * VALLON PHARMACEUTICALS REPORTS FISCAL YEAR 2021 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
    * VALLON PHARMACEUTICALS INC - TOPLINE DATA FOR PIVOTAL ABUSE STUDY OF
COMPANY'S
LEAD INVESTIGATIONAL PROGRAM ADAIREXPECTED THIS QUARTER
    * VALLON PHARMACEUTICALS INC- AS OF DECEMBER 31, 2021, COMPANY HAD CASH,
CASH
EQUIVALENTS AND MARKETABLE SECURITIES OF APPROXIMATELY $7.5 MILLION
    * VALLON PHARMACEUTICALS INC - SECOND DEVELOPMENT PROGRAM, ADMIR, CONTINUES
TO
ADVANCE WITH FIRST-IN-HUMANCLINICAL TRIAL EXPECTED TO COMMENCE IN 2022
    * VALLON PHARMACEUTICALS-  EXPECTS CASH, CASH EQUIVALENTS WILL PROVIDE
FUNDING FOR
ITS ONGOING DEVELOPMENT AND BUSINESS ACTIVITIES INTO Q3 OF 2022

Source text for Eikon:  ID:nGNX4P8M41 
Further company coverage:  VLON.O